Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10963030 | Vaccine | 2015 | 5 Pages |
Abstract
Brucella melitensis can be transmitted and cause disease in cattle herds as a result of inadequate management of mixed livestock farms. Ideally, vaccines against Brucella abortus for cattle should also provide cross-protection against B. melitensis. Previously we created a novel influenza viral vector B. abortus (Flu-BA) vaccine expressing the Brucella ribosomal proteins L7/L12 or Omp16. This study demonstrated Flu-BA vaccine with adjuvant Montanide Gel01 provided 100% protection against abortion in vaccinated pregnant heifers and good cross-protection of the heifers and their calves or fetuses (90-100%) after challenge with B. melitensis 16Â M; the level of protection provided by Flu-BA was comparable to the commercial vaccine B. abortus S19. In terms of the index of infection and colonization of Brucella in tissues, both vaccines demonstrated significant (PÂ =Â 0.02 to PÂ <Â 0.0001) protection against B. melitensis 16Â M infection compared to the negative control group (PBSÂ +Â Montanide Gel01). Thus, we conclude the Flu-BA vaccine provides cross-protection against B. melitensis infection in pregnant heifers.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Kaissar Tabynov, Sholpan Ryskeldinova, Abylai Sansyzbay,